Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 5/20 | 1.00 |
| ▸ | GABRP | O00591 | 2/20 | 0.46 |
| ▸ | GABRD | O14764 | 2/20 | 0.46 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.46 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.46 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.46 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.46 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.46 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.46 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.46 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.46 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.46 |
| ▸ | GABRE | P78334 | 2/20 | 0.46 |
| ▸ | GABRA6 | Q16445 | 2/20 | 0.46 |
| ▸ | GABRG1 | Q8N1C3 | 2/20 | 0.46 |
| ▸ | GABRG3 | Q99928 | 2/20 | 0.46 |
| ▸ | GABRQ | Q9UN88 | 2/20 | 0.46 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29502911 | 1.00 | KDM4E (1.00) | KDM4EGABRPGABRDGABRA1GABRB1 | |
| SCHEMBL11881146 | 0.89 | KDM4E (0.79) | KDM4EGABRPGABRDGABRA1GABRB1 | |
| SCHEMBL1553215 | 0.83 | KDM4E (0.70) | KDM4EGABRPGABRDGABRA1GABRB1 | |
| SCHEMBL2060597 | 0.83 | KDM4E (0.70) | KDM4ETDP1GAAALDH1A1LMNA | |
| SCHEMBL2771019 | 0.83 | KDM4E (0.70) | KDM4ETDP1GAAALDH1A1LMNA | |
| SCHEMBL5424439 | 0.83 | KDM4E (0.70) | KDM4EGABRPGABRDGABRA1GABRB1 | |
| Hydrochloric Acid SCHEMBL5430842 | 0.81 | KDM4E (0.68) | KDM4EGABRPGABRDGABRA1GABRB1 | |
| SCHEMBL6120291 | 0.81 | KDM4E (0.68) | KDM4EGABRPGABRDGABRA1GABRB1 | |
| SCHEMBL7038599 | 0.81 | KDM4E (0.68) | KDM4EGABRPGABRDGABRA1GABRB1 | |
| SCHEMBL10932482 | 0.81 | KDM4E (0.68) | KDM4EGABRPGABRDGABRA1GABRB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 282 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115010671-B | One-step synthesis method of 2-substituted quinazolinone | 江苏大学 | 2023-10-10 | — | — | CN | claimed |
| CN-115010671-A | One-step synthesis method of 2-substituted quinazolinone | 江苏大学 | 2022-09-06 | — | — | CN | claimed |
| CN-114836507-A | Screening method and application of amino acid degradation product with induction activity | 华南理工大学 | 2022-08-02 | — | — | CN | claimed |
| CN-114702671-A | Carboxylated crosslinked polyimide prepolymer and preparation method thereof | 江苏环峰电工材料有限公司 | 2022-07-05 | — | — | CN | claimed |
| CN-110551280-B | Liquid crystal polymer, preparation method thereof and flexible printed circuit board prepared from liquid crystal polymer | Nanjing Qingyan Polymer New Materials Co.,Ltd. (CN) | 2021-08-31 | — | — | CN | claimed |
| CN-110551280-A | Liquid crystal polymer, preparation method thereof and flexible printed circuit board prepared from liquid crystal polymer | NANJING QINGYAN POLYMER NEW MAT CO LTD | 2019-12-10 | — | — | CN | claimed |
| CN-106381026-B | A kind of high-hardness, wearable acrylic ester aquosity paint | 安徽省金盾涂料有限责任公司 | 2018-12-14 | — | — | CN | claimed |
| CN-106381026-A | High-hardness and high-wear-resistance acrylate water-based paint | 安徽省金盾涂料有限责任公司 | 2017-02-08 | — | — | CN | claimed |
| CN-106366899-A | High-wear-resistant antibacterial acrylate paint | 安徽省金盾涂料有限责任公司 | 2017-02-01 | — | — | CN | claimed |
| CN-104341370-A | Preparation method of cetilistat | SHANDONG CHUANGXIN PHARMACEUTICAL RES AND DEV CO LTD | 2015-02-11 | — | — | CN | claimed |
| WO-2008130924-A2 | ISOTOPICALLY-LABELED GLYCANS | MOMENTA PHARMACEUTICALS, INC. (US) | 2008-10-30 | — | — | WO | claimed |
| EP-0654659-B1 | Defined volume test device | BOEHRINGER MANNHEIM CORP (US) | 1997-02-12 | — | — | EP | claimed |
| EP-0345781-B1 | Defined volume test device | BOEHRINGER MANNHEIM CORP (US) | 1995-08-30 | — | — | EP | claimed |
| EP-0654659-A1 | Defined volume test device | BOEHRINGER MANNHEIM CORPORATION (US) | 1995-05-24 | — | — | EP | claimed |
| US-4994238-A | Constant volume chemical analysis test device | ROCHE DIABETES CARE, INC. | 1991-02-19 | — | — | US | claimed |
| EP-0345781-A2 | Defined volume test device | BOEHRINGER MANNHEIM CORPORATION (US) | 1989-12-13 | — | — | EP | claimed |
| US-20250171452-A1 | TRYPTANTHRIN DERIVATIVES AND USES THEREOF | VISCIENT BIO, INC. | 2025-05-29 | — | — | US | disclosed |
| EP-4514804-A1 | TRYPTANTHRIN DERIVATIVES AND USES THEREOF | Viscient Bio, Inc. (US) | 2025-03-05 | — | — | EP | disclosed |
| US-4087606-A | ANTIALLERGENS | AMERICAN HOME PRODUCTS CORPORATION (US) | 1978-05-02 | — | — | US | disclosed |
| US-4054591-A | ANTIALLERGIC AGENTS | AMERICAN HOME PRODUCTS CORPORATION (US) | 1977-10-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250171452-A1 | TRYPTANTHRIN DERIVATIVES AND USES THEREOF | IDO2, IDO1, TPSB2 | KDM4E 1128/4885GABRP 3537/4885GABRD 4100/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.